June Lee, MD
Professor
Medicine
School of Medicine
June Lee, MD, is a Professor in the School of Medicine at UCSF. She was the chief architect of the highly successful Clinical and Translational Science Institute's Catalyst Program which serves as an internal UCSF accelerator for therapeutics, devices, diagnostics, and digital health technologies. She also oversaw key strategic partnerships at UCSF to include industry collaborations.
Show full bio (110 words) Hide full bio
She also served as Chair of the Drug, Device, Discovery and Development (D4) workgroup of UC BRAID (University of California Biomedical Research Acceleration Integration and Development) and was previously the Vice-Chair of CTSA Translational Key Function Committee.
Prior to UCSF, she worked at Genentech where as the therapeutic area head, she led early clinical development programs in Infectious Diseases, Cardiovascular/Metabolic Diseases, and Respiratory Diseases. In that role, she was responsible for the clinical strategy and execution of programs in the early clinical development stages and successfully developed pre-clinical and late stage research projects in a variety of therapeutic areas through IND clearance and early stage clinical proof of concept studies.
Education & Training
Show all (2) Hide
- M.D. School of Medicine University of California, Davis 1992
- B.S. Chemistry Johns Hopkins University 1988
Websites
Show all (2) Hide
- @@juneleemd on Twitter (twitter.com)
- UCSF Catalyst Program (ctsi.ucsf.edu)
Grants and Projects
Show all (3) Hide
Publications (13)
Top publication keywords:
SpirometryInterleukin-13Delivery of Health CareAnti-Asthmatic AgentsBronchoconstrictionForced Expiratory VolumeLymphotoxin-alphaAsthmaRespiratory SystemAlbuterolAndrostadienesImmunoglobulin ESkin TestsTranscription, GeneticAllergens
-
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2014 Scheerens H, Arron JR, Zheng Y, Putnam WS, Erickson RW, Choy DF, Harris JM, Lee J, Jarjour NN, Matthews JG -
Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.
Arthritis research & therapy 2012 Emu B, Luca D, Offutt C, Grogan JL, Rojkovich B, Williams MB, Tang MT, Xiao J, Lee JH, Davis JC -
Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008 Haselkorn T, Lee JH, Mink DR, Weiss ST, TENOR Study Group -
The response to combination therapy treatment regimens in severe/difficult-to-treat asthma.
The European respiratory journal 2008 Campbell JD, Borish L, Haselkorn T, Rasouliyan L, Lee JH, Wenzel SE, Sullivan SD, TENOR Study Group -
Insurance status and asthma-related health care utilization in patients with severe asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008 Peters AT, Klemens JC, Haselkorn T, Weiss ST, Grammer LC, Lee JH, Chen H, TENOR Study Group
Show all (8 more) Hide
-
Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.
Chest 2007 Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE -
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.
The Journal of allergy and clinical immunology 2007 Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y, Lee JH, TENOR Study Group -
Recent asthma exacerbations: a key predictor of future exacerbations.
Respiratory medicine 2006 Miller MK, Lee JH, Miller DP, Wenzel SE, TENOR Study Group -
TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.
The European respiratory journal 2006 Miller MK, Lee JH, Blanc PD, Pasta DJ, Gujrathi S, Barron H, Wenzel SE, Weiss ST, TENOR Study Group -
Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study.
The Journal of asthma : official journal of the Association for the Care of Asthma 2006 Lee JH, Haselkorn T, Chipps BE, Miller DP, Wenzel SE, Tenor Study Group -
Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006 Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE, TENOR Study Group -
Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types.
American journal of respiratory cell and molecular biology 2001 Lee JH, Kaminski N, Dolganov G, Grunig G, Koth L, Solomon C, Erle DJ, Sheppard D -
Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.
Molecular and cellular biology 2000 Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV, Sheppard D